The store will not work correctly when cookies are disabled.
cis-Diamineplatinum (II) Complex
ID: ALA430109
Max Phase: Preclinical
Molecular Formula: C11H20N2NaO5PPt
Molecular Weight: 509.33
Molecule Type: Small molecule
Associated Items:
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 509.33 | Molecular Weight (Monoisotopic): 509.0655 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
1. Hollis LS, Miller AV, Amundsen AR, Schurig JE, Stern EW.. (1990) cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents., 33 (1): [PMID:2296007] [10.1021/jm00163a018] |